Pharmaceutical

Hipra’s Covid-19 booster gets EMA nod and enters an unc...

As the EMA recommends Bimervax's as a booster, global plans for Covid-19 vaccin...

Medicines Patent Pool broadens access to generic inject...

The agreements could broaden the access to the GSK/ViiV’s long-acting PrEP in lo...

GSK signs licence deal with Scynexis for fungal infecti...

Ibrexafungerp is now being evaluated in Phase III clinical trials to treat invas...

Moderna to set up new mRNA manufacturing facility in Kenya

The facility is expected to enable manufacturing of drug products for Kenya and ...

US FDA launches lupus consortium to confront drug devel...

The agency is partnering with the Lupus Research Alliance to tackle therapeutic ...

How improved plain language summaries can boost your CT...

Better patient engagement is shown to improve the quality and equitability of cl...

MSD secures full approval for Keytruda’s use in MSI-hig...

The approval’s announcement comes amidst a drive for an overhaul of the accelera...

FDA tackles opioid crisis with OTC Narcan approval

In alignment with its Overdose Prevention Framework, the US FDA approved the nal...

FDA $7bn plans for 2024: disclose contract manufacturer...

For medical products specifically (drugs, diagnostics, and devices), the FDA is ...

STAT+: Solicitor general urges Supreme Court to review ...

“It looks like the Solicitor General is siding with Teva by requesting the Supre...

STAT+: Drug middlemen switch tactics, but the outcome i...

Prescription drug middlemen are shifting away from rebates to increasingly large...

Gunshot injuries surged in U.S. during pandemic, CDC says

A new CDC study highlights just how violent the recent past has been in the U.S....

Listen: Biotech’s monkey shortage, the broken generics ...

What happened to the market for monkeys? Are some drugs too cheap? And why are b...

STAT+: FDA proposes a new plan to streamline updates to...

The FDA has released a new plan allowing developers of medical devices that rely...

Texas judge strikes down major Obamacare provision prot...

A federal judge Thursday reversed a major Obamacare provision requiring plans to...

STAT+: Pharmalittle: FDA approves over-the-counter Narc...

The FDA approved selling Narcan without a prescription, setting the overdose-rev...